Vera Binder

Dr. Von Hauner'sches Kinderspital
Munich, BY 80337, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications

Human-Level Differentiation of Medulloblastoma from Pilocytic Astrocytoma: A Real-World Multicenter Pilot Study.

Human-Level Differentiation of Medulloblastoma from Pilocytic Astrocytoma: A Real-World Multicenter Pilot Study.

Journal: Cancers
Published: March 12, 2024

Ing4-deficiency promotes a quiescent yet transcriptionally poised state in hematopoietic stem cells.

Ing4-deficiency promotes a quiescent yet transcriptionally poised state in hematopoietic stem cells.

Journal: iScience
Published: March 15, 2023

Partial upper limb salvage after resection of Ewing sarcoma of the distal humerus.

Partial upper limb salvage after resection of Ewing sarcoma of the distal humerus.

Journal: Pediatric blood & cancer
Published: December 28, 2022

Microenvironmental control of hematopoietic stem cell fate via CXCL8 and protein kinase C.

Microenvironmental control of hematopoietic stem cell fate via CXCL8 and protein kinase C.

Journal: Cell reports
Published: March 13, 2022

Leukemia escape in immune desert: intraocular relapse of pediatric pro-B-ALL during systemic control by CD19-CAR T cells.

Leukemia escape in immune desert: intraocular relapse of pediatric pro-B-ALL during systemic control by CD19-CAR T cells.

Journal: Journal for immunotherapy of cancer
Published: August 06, 2020

In vivo inducible reverse genetics in patients' tumors to identify individual therapeutic targets.

In vivo inducible reverse genetics in patients' tumors to identify individual therapeutic targets.

Journal: Nature communications
Published: June 18, 2020

CLEC12A and CD33 coexpression as a preferential target for pediatric AML combinatorial immunotherapy.

CLEC12A and CD33 coexpression as a preferential target for pediatric AML combinatorial immunotherapy.

Journal: Blood
Published: May 11, 2020

Antiemetic Prophylaxis with Fosaprepitant and 5-HT3-Receptor Antagonists in Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation.

Antiemetic Prophylaxis with Fosaprepitant and 5-HT3-Receptor Antagonists in Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation.

Journal: Drug design, development and therapy
Published: May 06, 2020

Venetoclax and decitabine for relapsed paediatric myelodysplastic syndrome-related acute myeloid leukaemia with complex aberrant karyotype after second stem cell transplantation.

Venetoclax and decitabine for relapsed paediatric myelodysplastic syndrome-related acute myeloid leukaemia with complex aberrant karyotype after second stem cell transplantation.

Journal: British journal of haematology
Published: April 29, 2020

Leukemia-induced dysfunctional TIM-3+CD4+ bone marrow T cells increase risk of relapse in pediatric B-precursor ALL patients.

Leukemia-induced dysfunctional TIM-3+CD4+ bone marrow T cells increase risk of relapse in pediatric B-precursor ALL patients.

Journal: Leukemia
Published: September 24, 2019

Author Correction: Epoxyeicosatrienoic acids enhance embryonic haematopoiesis and adult marrow engraftment.

Author Correction: Epoxyeicosatrienoic acids enhance embryonic haematopoiesis and adult marrow engraftment.

Journal: Nature
Published: August 23, 2019

Efficacy, safety and feasibility of fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting in pediatric patients receiving moderately and highly emetogenic chemotherapy - results of a non-interventional observation study.

Efficacy, safety and feasibility of fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting in pediatric patients receiving moderately and highly emetogenic chemotherapy - results of a non-interventional observation study.

Journal: BMC cancer
Published: May 03, 2019
Showing 1-12 of 24

Last Updated: 09/26/2026